Glenview Trust’s Synopsys SNPS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-471
Closed -$221K 515
2025
Q4
$221K Sell
471
-90
-16% -$40K ﹤0.01% 468
2025
Q3
$277K Buy
561
+119
+27% +$67.3K ﹤0.01% 439
2025
Q2
$227K Sell
442
-58
-12% -$27K ﹤0.01% 472
2025
Q1
$214K Buy
500
+34
+7% +$16.5K ﹤0.01% 454
2024
Q4
$226K Hold
466
﹤0.01% 453
2024
Q3
$236K Sell
466
-57
-11% -$30.6K ﹤0.01% 441
2024
Q2
$311K Buy
523
+45
+9% +$25.4K 0.01% 398
2024
Q1
$273K Sell
478
-4
-0.8% -$2.2K 0.01% 411
2023
Q4
$248K Buy
+482
New +$246K 0.01% 428

Other funds holding SNPS

Glenview Trust's SNPS Position: Q1 2026 in Review

Glenview Trust sold out of Synopsys (SNPS) in Q1 2026, closing a stake of 471 shares — an estimated $221K sold.

Glenview Trust first reported a position in SNPS in Q4 2023 and held it in 9 quarters. The position peaked at $311K in Q2 2024. 1,390 funds tracked by Wall St. Rank hold SNPS as of Q1 2026.

  • Glenview Trust reported no remaining Synopsys position as of Q1 2026 after selling out during the quarter.
  • Glenview Trust sold 471 Synopsys shares in Q1 2026, an estimated $221K.
  • Glenview Trust first reported a position in Synopsys in Q4 2023 and held it in 9 quarters.
  • Glenview Trust's Synopsys position peaked at $311K in Q2 2024.
  • 1,390 funds tracked by Wall St. Rank held Synopsys as of Q1 2026.

Based on Glenview Trust's 13F filing for Q1 2026, filed 8 May 2026.